RAPS Workshop: Mastering Notified Body Opinions for Drug-Device Combination Products under EU MDR 2017/745
Virtual Programs 
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsCombination products/companion diagnosticsFoundationalHealth Authority meeting and communication strategyMedical DevicesNotified BodiesPharmaceuticalsPharmacovigilancePreclinical studyProduct developmentProfessional Development/TrainingRegulatory Intelligence/PolicyRegulatory writing/documentationResearch, Design and DevelopmentRisk managementUnited States